VXRT: Vaxart, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 189.93
Enterprise Value ($M) 150.93
Book Value ($M) 80.01
Book Value / Share 0.35
Price / Book 2.37
NCAV ($M) 37.80
NCAV / Share 0.17
Price / NCAV 5.02

Profitability (mra)
Return on Invested Capital (ROIC) -0.73
Return on Assets (ROA) -0.72
Return on Equity (ROE) -1.06

Liquidity (mrq)
Quick Ratio 4.54
Current Ratio 4.54

Balance Sheet (mrq) ($M)
Current Assets 71.53
Assets 113.75
Liabilities 33.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 4.63 0.36
01-19 13G Ra Capital Management, L.p. 9.10

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-29 303,841 952,792 31.89
2024-10-28 300,270 1,103,974 27.20
2024-10-25 458,206 1,345,903 34.04
2024-10-24 125,875 461,574 27.27

(click for more detail)

Similar Companies
VSTM – Verastem, Inc. VTGN – Vistagen Therapeutics, Inc.
VTVT – vTv Therapeutics Inc. VYNE – VYNE Therapeutics Inc.
WINT – Windtree Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Vaxart Inc